CROSS CANCER INSTITUTE AT UNIVERSITY OF ALBERTA
| Site name: | Cross Cancer Institute at University of Alberta | Active Prostate Cancer Clinical Trials: | |
| Contact: | Peter Venner | That match your search: | No search performed |
| Phone: | 780-432-8757 | ||
| Site email: | Not Provided |
5
Active Prostate Cancer Clinical Trials at Cross Cancer Institute at University of Alberta:
| TRIAL ID | TITLE | TRIAL PHASE |
|---|---|---|
| NCT00002651 | Intermittent Androgen Deprivation in Patients With Stage D2 Prostate Cancer, Phase III | Phase 3 |
| NCT00567580 | A Phase III Trial of Short Term Androgen Deprivation With Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients With a Rising PSA After Radical Prostatectomy | Phase 3 |
| NCT00079001 | A Randomized Double-Blind, Placebo-Controlled Phase III Study of Early Versus Standard Zoledronic Acid to Prevent Skeletal Related Events in Men With Prostate Cancer Metastatic to Bone | Phase 3 |
| NCT00063882 | A Phase III Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy With Brachytherapy Alone for Selected Patients With Intermediate Risk Prostatic Carcinoma | Phase 3 |
| NCT00450411 | A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy | Phase 2 |